SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending after delivering a strong earnings beat and significantly raised FY27 guidance, with robust cloud and AI infrastructure growth, leading the community to hail it as a validation of AI spending and a powerful rebuttal to prior capital expenditure concerns plaguing the software sector.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is experiencing significant volatility, driven by strong AI-fueled earnings from Oracle providing a bullish catalyst, alongside ongoing geopolitical tensions in the Middle East and conflicting reports impacting oil routes. The community is actively debating whether market movements are algorithmic 'pumps' or fundamental shifts, as traders anticipate upcoming economic data.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as the FDA lifts its Complete Response Letter for the Duchenne Muscular Dystrophy therapy, Deramiocel, and sets a new PDUFA date, a development celebrated by the community eager for accelerated approval and potential buyout after a controversial FDA official's imminent departure. Investors are also keenly anticipating high-impact data from an upcoming medical conference and updates on the promising StealthX exosome platform.

UniFirst Corp. engages in the provision of workplace uniforms and protective work wear clothing. It operates through following segments: the United States and Canadian Rental and Cleaning, Manufacturing (MFG), Specialty Garments, First Aid, and Corporate. The U.S. and Canadian Rental and Cleaning segment purchases, rents, cleans, delivers, and sells uniforms, protective clothing, and non-garment items. The MFG segment designs and manufactures uniforms and non-garment items. The Specialty Garments segment is involved in nuclear and cleanroom applications and provides cleanroom cleaning services. The First Aid segment focuses on first aid cabinet services and other safety supplies. The Corporate segment includes distribution, sales and marketing, information systems, engineering, materials management, manufacturing planning, finance, budgeting, human resources, and other general and administrative costs and interest expense. The company was founded by Aldo Croatti in 1936 and is headquartered in Wilmington, MA.

Unifirst Corp.

UniFirst is trending as Cintas has announced a definitive agreement to acquire the uniform rental company, marking a significant development after a prolonged M&A saga. The community is actively discussing the substantial acquisition premium and the broader consolidation within the uniform services sector.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath (PATH) is experiencing heightened investor attention leading into its upcoming earnings report, with recent AIUC-1 certification underscoring its pivotal role in secure enterprise AI agent orchestration. This has fueled a polarized community debate, with bulls anticipating a significant short squeeze and fundamental strength in Agentic AI, while bears express concerns over competition and valuation, driving notable price volatility.

TSS, Inc. engages in the provision of comprehensive services for the planning, design, development and maintenance of mission-critical facilities and information infrastructure as well as integration services. It operates through the Facilities and Systems Integration Services business segments. The Facilities segment consists of the design, project management, and maintenance of data center and mission-critical business operations. The Systems Integration segment integrates information technology equipment for original equipment manufacturer vendors and customers to be used inside data center environments, including modular data centers. The company was founded by Gerard J. Gallagher on December 20, 2004 and is headquartered in Round Rock, TX.

TSS Inc

TSSI is trending ahead of its highly anticipated Q4 earnings, with community sentiment driven by an earlier-than-expected release date and strong tailwinds from key partner Dell's surging AI server backlog. Investors are closely watching for a potential beat and positive guidance, fueled by the company's low float, high short interest, and its critical role in the ongoing AI data center infrastructure buildout.

Canadian Solar, Inc. engages in the manufacture of solar photovoltaic modules, provision of solar energy and battery storage solutions, and development of utility-scale solar and battery storage products. It operates through the CSI Solar and Global Energy segments. The CSI Solar segment designs, develops, and manufactures solar ingots, wafers, cells, modules, and other solar power and battery storage products. The Global Energy segment includes solar and battery storage project development and sale, asset management services for operational projects, sale of electricity, and investment in retained assets. The company was founded by Shawn Qu in October 2001 and is headquartered in Kitchener, Canada.

Canadian Solar Inc

The community is intensely debating Canadian Solar's valuation, alleging market manipulation and "fraud prints" that keep its price artificially low despite a recent notes offering at a substantial premium and positive news like a key patent win. Investors eagerly anticipate upcoming Q4 earnings and long-term tailwinds from US manufacturing and growing energy storage demand.

The Internet Computer is a decentralized cloud blockchain designed to run applications, websites, and backend systems fully on-chain. Its architecture provides robust security, resilience, and built-in multi-chain support.  A key focus of the network is enabling a “self-writing cloud,” where AI tools allow users generate applications through natural-language instructions.  Developers and users can experiment with the platform using AI app-generation tools like caffeine.ai or by writing serverless code directly through online IDEs such as icp.ninja.  The ICP token is used to pay for computation (through a burn-based model) and to participate in network governance through staking.

Internet Computer

Internet Computer (ICP) is a hot topic, fueled by discussions around its Mission 70 initiative to reduce inflation and growing real-world adoption with projects like the Swiss Subnet and AI integrations. While many see its unique decentralized infrastructure as a long-term asymmetric bet, others remain skeptical, citing historical price underperformance and concerns over continuous token minting.

Serve Robotics, Inc. engages in providing self-driving delivery. It designs, develops, and operates zero-emissions robots that serve people in public spaces, starting with food delivery. The company was founded by Ali Kashani, Dmitry Demeshchuk and MJ Burk Chun in 2017 and is headquartered in Redwood City, CA.

Serve Robotics Inc

Serve Robotics is trending as its acquisition of Diligent Robotics signals an expansion into healthcare, while NVIDIA's public endorsement highlights its "Physical AI" in urban delivery. The community is actively debating the company's growth potential and short-squeeze prospects, balancing optimism from new markets and partnerships against valuation and profitability concerns.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is trending as its updated executive compensation, including potential "golden parachutes," fuels widespread community speculation about a significant M&A or takeover within the consolidating AI data training sector. Investors are closely watching upcoming earnings for clarity on the company's ambitious growth trajectory in areas like defense and AI robotics, debating whether conservative guidance will be exceeded or if it will become an acquisition target.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MannKind (NASDAQ:MNKD) CEO Buys $259,000.00 in Stock

MannKind Corporation (NASDAQ:MNKD - Get Free Report) CEO Michael Castagna acquired 100,000 shares of the business's stock in a transaction that occurred on Tuesday, March 10th. The shares were...

MannKind (NASDAQ:MNKD) Hits New 12-Month Low - Here's Why

MannKind (NASDAQ:MNKD) Reaches New 1-Year Low - Here's Why...

MannKind Corporation $MNKD Shares Acquired by JPMorgan Chase & Co.

JPMorgan Chase & Co. boosted its position in shares of MannKind Corporation (NASDAQ:MNKD - Free Report) by 51.5% in the third quarter, according to the company in its most recent 13F filing with the...

MannKind (NASDAQ:MNKD) Price Target Lowered to $8.00 at Wedbush

Wedbush decreased their price objective on shares of MannKind from $10.00 to $8.00 and set an "outperform" rating for the company in a report on Thursday...

MannKind (NASDAQ:MNKD) Sets New 1-Year Low - Here's What Happened

MannKind (NASDAQ:MNKD) Hits New 12-Month Low - Should You Sell...

MannKind (NASDAQ:MNKD) Stock Price Down 6.6% After Analyst Downgrade

MannKind (NASDAQ:MNKD) Shares Down 6.6% Following Analyst Downgrade...

MannKind Corporation (NASDAQ:MNKD) Given Average Recommendation of "Moderate Buy" by Analysts

MannKind Corporation (NASDAQ:MNKD - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the nine ratings firms that are covering the company, Marketbeat reports. Three...

MannKind at Oppenheimer: 2025 Revenue Jumps 46%, Eyes $450M+ in 2026 on Afrezza and FUROSCIX

MannKind (NASDAQ:MNKD) executives highlighted accelerating revenue growth, pipeline priorities, and commercialization plans during a discussion at Oppenheimer's 36th Annual Healthcare Life Sciences...

MannKind (NASDAQ:MNKD) Stock Rating Lowered by Wall Street Zen

Wall Street Zen cut shares of MannKind from a "buy" rating to a "hold" rating in a report on Saturday...

Wells Fargo & Company Has Lowered Expectations for MannKind (NASDAQ:MNKD) Stock Price

Wells Fargo & Company dropped their price objective on MannKind from $8.00 to $7.00 and set an "overweight" rating on the stock in a research note on Friday...

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

MNKD
Mannkind Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MNKD News

MNKDMannkind Corp